N/A
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer / Rocco, Bernardo Maria Cesare; Ferrari, M; Scardino, E; Matei, Dv; Verweij, F; Varela, R; De Cobelli, O.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 25:1B(2005), pp. 577-578.
Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer
ROCCO, Bernardo Maria Cesare;
2005
Abstract
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
